Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
ascopubs.org
17y

A multi-center, open label trial to evaluate the efficacy and tolerability of aprepitant (A) and palonosetron (P) for the prevention of chemotherapy-induced nausea and vomiting ...

This is an ASCO Meeting Abstract from the 2008 ASCO Annual Meeting. This abstract does not include a full text component.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Resigns as FDA chief
US inflation surged in April
Proposes bill to rename US-287
US Air Force jet crashes
‘One Life to Live’ star dies
Golden Dome estimate
14 missing after boat sinks
Jeff Probst's brother dies
Journalist, film critic dies
Grizzlies' forward dies
Judge grants records access
Man pleads guilty in theft
Runway death ruled suicide
Ship operator, staff charged
Missing ASU student found dead
New gang violence in Haiti
Morey out as 76ers president
Waymo recalls robotaxis
El Paso signs Fernández
Nigerian airstrike kills 100
Coyle signs 6-yr, $36M deal
NBA's LGBTQ trailblazer dies
Strikes deal with hackers
To become BuzzFeed CEO
Rejects GameStop’s $56B bid
Reaches settlement with DOJ
Warsh confirmed by Senate
Gives EU companies AI access
Disney World’s chief to retire
Launches 30-minute delivery
Hit with subpoena
PCOS gets new name
Patel testifies before Senate
  • Privacy
  • Terms